These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 11759179)

  • 1. The effects of sublingual glyceryl trinitrate on walking distance in patients with intermittent claudication. A randomised, doubled-blind, placebo-controlled, cross-over study.
    Heer R; Walker S; MacSweeney S
    Curr Med Res Opin; 2001; 17(2):113-5. PubMed ID: 11759179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled, crossover study to assess the immediate effect of sublingual glyceryl trinitrate on the ankle brachial pressure index, claudication, and maximum walking distance of patients with intermittent claudication.
    Walker SR; Tennant S; MacSweeney ST
    J Vasc Surg; 1998 Nov; 28(5):895-900. PubMed ID: 9808859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular surgical society of great britain and ireland: prospective randomized double-blind placebo-controlled crossover study to assess the effect of sublingual glyceryl trinitrate in patients with intermittent claudication.
    Walker SR; Heer R; MacSweeney ST
    Br J Surg; 1999 May; 86(5):694. PubMed ID: 10361320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS).
    Kieffer E; Bahnini A; Mouren X; Gamand S
    Int Angiol; 2001 Mar; 20(1):58-65. PubMed ID: 11342997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent Administration of Nitroglycerin Sublingual Powder Compared with Placebo in Outpatients with Peripheral Artery Disease: Results of a Randomised Proof of Concept Study.
    Lawall H; Bramlage P; Gorath M; Wittig T
    Eur J Vasc Endovasc Surg; 2021 Mar; 61(3):457-465. PubMed ID: 33358350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study.
    Nenci GG; Gresele P; Ferrari G; Santoro L; Gianese F;
    Thromb Haemost; 2001 Nov; 86(5):1181-7. PubMed ID: 11816704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials.
    Hood SC; Moher D; Barber GG
    CMAJ; 1996 Oct; 155(8):1053-9. PubMed ID: 8873633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the oral hypoglycaemic sulphonylurea glibenclamide, a blocker of ATP-sensitive potassium channels, on walking distance in patients with intermittent claudication.
    Mortensen UM; Nielsen-Kudsk JE; Sondergaard HM; Jakobsen P; Jensen BS; Schmitz O; Nielsen TT
    Diabet Med; 2006 Mar; 23(3):327-30. PubMed ID: 16492219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of long-distance intermittent claudication with pentoxifylline: a 12-month, randomized trial.
    De Sanctis MT; Cesarone MR; Belcaro G; Nicolaides AN; Griffin M; Incandela L; Bucci M; Geroulakos G; Ramaswami G; Vasdekis S; Agus G; Bavera P; Ippolito E
    Angiology; 2002; 53 Suppl 1():S13-7. PubMed ID: 11865829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of intermittent claudication with pentoxifylline: a 12-month, randomized trial--walking distance and microcirculation.
    De Sanctis MT; Cesarone MR; Belcaro G; Nicolaides AN; Griffin M; Incandela L; Bucci M; Geroulakos G; Ramaswami G; Vasdekis S; Agus G; Bavera P; Ippolito E
    Angiology; 2002; 53 Suppl 1():S7-12. PubMed ID: 11865838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propionyl-L-carnitine in intermittent claudication: double-blind, placebo-controlled, dose titration, multicenter study.
    Brevetti G; Perna S; Sabbá C; Martone VD; Condorelli M
    J Am Coll Cardiol; 1995 Nov; 26(6):1411-6. PubMed ID: 7594063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of iloprost in patients with intermittent claudication.
    Creager MA; Pande RL; Hiatt WR
    Vasc Med; 2008 Feb; 13(1):5-13. PubMed ID: 18372433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of the walking ability in intermittent claudication due to superficial femoral artery occlusion with supervised exercise and pneumatic foot and calf compression: a randomised controlled trial.
    Kakkos SK; Geroulakos G; Nicolaides AN
    Eur J Vasc Endovasc Surg; 2005 Aug; 30(2):164-75. PubMed ID: 15890545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparan sulfate in the treatment of intermittent claudication: results of a randomized, double-blind, placebo-controlled multicenter trial.
    Messa GL; Gelso E
    Drugs Exp Clin Res; 2002; 28(1):37-48. PubMed ID: 12073766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A non-randomised controlled trial of the clinical and cost effectiveness of a Supervised Exercise Programme for claudication.
    Lee HL; Mehta T; Ray B; Heng MS; McCollum PT; Chetter IC
    Eur J Vasc Endovasc Surg; 2007 Feb; 33(2):202-7. PubMed ID: 17142065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of patients with severe intermittent claudication and the effect of treatment with naftidrofuryl.
    Moody AP; al-Khaffaf HS; Lehert P; Harris PL; Charlesworth D
    J Cardiovasc Pharmacol; 1994; 23 Suppl 3():S44-7. PubMed ID: 7517477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective, randomized, placebo-controlled trial of transdermal glyceryl trinitrate in ERCP: effects on technical success and post-ERCP pancreatitis.
    Kaffes AJ; Bourke MJ; Ding S; Alrubaie A; Kwan V; Williams SJ
    Gastrointest Endosc; 2006 Sep; 64(3):351-7. PubMed ID: 16923481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral nitric-oxide donor glyceryl-trinitrate induces sensitization in spinal cord pain processing in migraineurs: a double-blind, placebo-controlled, cross-over study.
    Perrotta A; Serrao M; Tassorelli C; Arce-Leal N; Guaschino E; Sances G; Rossi P; Bartolo M; Pierelli F; Sandrini G; Nappi G
    Eur J Pain; 2011 May; 15(5):482-90. PubMed ID: 20965755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent claudication: exercise-increased walking distance is not related to improved cardiopulmonary fitness.
    Ng PW; Hollingsworth SJ; Luery H; Kumana TJ; Chaloner EJ
    Eur J Vasc Endovasc Surg; 2005 Oct; 30(4):391-4. PubMed ID: 15963739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of severe intermittent claudication with pentoxifylline: a 40-week, controlled, randomized trial.
    Cesarone MR; Belcaro G; Nicolaides AN; Griffin M; De Sanctis MT; Incandela L; Geroulakos G; Ramaswami G; Cazaubon M; Barsotti A; Vasdekis S; Bavera P; Ippolito E
    Angiology; 2002; 53 Suppl 1():S1-5. PubMed ID: 11865828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.